The state of deprescribing research: How did we get here?

Emily Reeve; Wade Thompson; Cynthia Boyd; Carina Lundby; Michael A. Steinman

doi:10.1111/bcpt.13862

The state of deprescribing research: How did we get here?

Emily Reeve, Wade Thompson, Cynthia Boyd, Carina Lundby, Michael A. Steinman

Centre for Medicine Use and Safety

Research output: Contribution to journal › Comment / Debate › Other › peer-review

7 Citations (Scopus)

Abstract

The term deprescribing first appeared in the English medical literature in 20031; however, use of the term did not catch on widely until about 2016 and it has had an exponential rise in use in academia since then. Deprescribing is the process of withdrawal of medications where the harms outweigh the benefits (in the individual), supervised by a healthcare professional.

Original language	English
Pages (from-to)	657-660
Number of pages	4
Journal	Basic & Clinical Pharmacology & Toxicology
Volume	133
Issue number	6
DOIs	https://doi.org/10.1111/bcpt.13862
Publication status	Published - Dec 2023

Keywords

deprescribing
pharmacoepidemiology
polypharmacy
potentially inappropriate medication use
translation to practice

Access to Document

10.1111/bcpt.13862

Cite this

@article{24db0d6d342c452a96892cfb073f8468,

title = "The state of deprescribing research: How did we get here?",

abstract = "The term deprescribing first appeared in the English medical literature in 20031; however, use of the term did not catch on widely until about 2016 and it has had an exponential rise in use in academia since then. Deprescribing is the process of withdrawal of medications where the harms outweigh the benefits (in the individual), supervised by a healthcare professional.",

keywords = "deprescribing, pharmacoepidemiology, polypharmacy, potentially inappropriate medication use, translation to practice",

author = "Emily Reeve and Wade Thompson and Cynthia Boyd and Carina Lundby and Steinman, {Michael A.}",

note = "Funding Information: Dr Reeve is supported by an NHMRC Investigator Grant (GNT1195460) and grants from the US National Institutes of Health (R33‐AG057289 and R01‐AG070047‐01). Drs Boyd and Steinman are funded by the US National Institutes of Health (both R24AG064025, and Dr Steinman: K24AG049057 and Dr Boyd: 1K24AG056578). ",

year = "2023",

month = dec,

doi = "10.1111/bcpt.13862",

language = "English",

volume = "133",

pages = "657--660",

journal = "Basic & Clinical Pharmacology & Toxicology",

issn = "1742-7835",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - The state of deprescribing research

T2 - How did we get here?

AU - Reeve, Emily

AU - Thompson, Wade

AU - Boyd, Cynthia

AU - Lundby, Carina

AU - Steinman, Michael A.

N1 - Funding Information: Dr Reeve is supported by an NHMRC Investigator Grant (GNT1195460) and grants from the US National Institutes of Health (R33‐AG057289 and R01‐AG070047‐01). Drs Boyd and Steinman are funded by the US National Institutes of Health (both R24AG064025, and Dr Steinman: K24AG049057 and Dr Boyd: 1K24AG056578).

PY - 2023/12

Y1 - 2023/12

N2 - The term deprescribing first appeared in the English medical literature in 20031; however, use of the term did not catch on widely until about 2016 and it has had an exponential rise in use in academia since then. Deprescribing is the process of withdrawal of medications where the harms outweigh the benefits (in the individual), supervised by a healthcare professional.

AB - The term deprescribing first appeared in the English medical literature in 20031; however, use of the term did not catch on widely until about 2016 and it has had an exponential rise in use in academia since then. Deprescribing is the process of withdrawal of medications where the harms outweigh the benefits (in the individual), supervised by a healthcare professional.

KW - deprescribing

KW - pharmacoepidemiology

KW - polypharmacy

KW - potentially inappropriate medication use

KW - translation to practice

UR - http://www.scopus.com/inward/record.url?scp=85153313662&partnerID=8YFLogxK

U2 - 10.1111/bcpt.13862

DO - 10.1111/bcpt.13862

M3 - Comment / Debate

C2 - 36973899

AN - SCOPUS:85153313662

SN - 1742-7835

VL - 133

SP - 657

EP - 660

JO - Basic & Clinical Pharmacology & Toxicology

JF - Basic & Clinical Pharmacology & Toxicology

IS - 6

ER -

The state of deprescribing research: How did we get here?

Abstract

Keywords

Access to Document

Other files and links

Integration and implementation of deprescribing recommendations to reduce medication induced harm

Cite this

The state of deprescribing research: How did we get here?

Abstract

Keywords

Access to Document

Other files and links

Projects

Integration and implementation of deprescribing recommendations to reduce medication induced harm

Cite this